Partners

A businessman and a businesswoman shake hands

Thank you to our partners. Your support makes all the difference!

 

Corporate Partners

National Program Partners

International Partners

Research Partnerships


Corporate Partners

The Canadian Liver Foundation recognizes that the fight against liver disease is not easy and is bigger than any single organization. The CLF is proud to work in partnership with many organizations that believe in and support our mission of bringing liver research to life.

There are a variety of ways your organization can partner with the CLF and achieve your own business objectives in the process.

  • Sponsoring an event or campaign is a strategic way to achieve your marketing objectives. When supporting any of our national campaigns or fundraising initiatives like Liver Health Month, the LIVERight Gala, the STROLL For LIVER or our LIVERight Health Forum at the regional or national level, we will work with you to develop a sponsorship program that enables you to meet your business objectives, while maximizing your investment.
  • Cause marketing is a form of marketing in which a company and a charity work together to tackle a social or environmental problem while concurrently creating business value for the company. Commonly in cause marketing a brand will be associated with a cause and a portion of the proceeds from that product or service sale is directed to the cause.
  • Employee engagement in corporate giving is a great way to support a strong corporate culture. You can involve employees through matched donations, fundraising challenges or volunteerism; the CLF will work with your organization to customize a program that meets your objectives.

For partnership opportunities please contact Karen Seto.


Event Sponsors

STROLL for LIVER

Regional
Degrees Diner (MB)
Fairchild TV (BC)
Global BC (BC)
Ingham Pharmacy (MB)
Kenroc Building Materials (MB)
McGilivary Costco Wholesale (MB)
Royal Bank (AB)
SafetyLine (BC)
Solo Market (MB)
Specialty Rx. Solutions (ON)
Superior Tofu (BC)
Talentvision (BC)
Toronto School of Traditional Chinese Medicine (ON)
Vancouver Bullion & Currency Exchange (BC)

LIVERight Gala

National

Astellas
Gilead Science Canada
Specialty Rx Solutions

Regional
Appleseed (BC)
Air Canada (BC)
Blitzgear (BC)
Café Gloucester (BC)
Cal Wenzel Family Foundation (AB)
CTV (AB)
Golden Star Resources (ON)
Jaquar Land Rover (BC)
London Drugs (BC)
Manyee Lui (BC)
Patsy Hui (BC)
Sanboutei (BC)
ScotiaBank (BC)
TPH (AB)
VBCE (BC)
Velas Resort Mexico (BC)

LIVERight Health Forum

National
Gilead Science Canada

Regional
Advanced Care Pharmacy (AB)
Advanced Care Specialty Pharmacy (BC)
Fairchild TV (BC)
Khalsa Credit Union (BC)
Manitoba Community Services Council (MB)
Merck Canada (AB) (BC)
Ming Pao (BC)
Pharmacy at Safeway (BC) 
Pacific Blue Cross (BC)
Richmond Chinatown Lions Club (BC)
Sing Tao (BC)
Winnipeg Foundation (MB)

For regional event partnership opportunities available please contact Karen Lyon.

 

National Program Partners

The Canadian Liver Foundation is proud to partner and work with organizations across the country that have made liver health a priority in their initiatives. We are truly grateful for the support received from organizations supporting our national awareness initiatives.

Federated Health Charities logo
Federated Health Charities Campaign

Members of the Ontario Public Service (OPS) support the Canadian Liver Foundation’s liver research, education and patient support programs through payroll deductions, donations and special events.

HealthPartners logo
HealthPartners
Employees and employers of the national, provincial and municipal public sectors are engaged in the HealthPartners campaign to support the Canadian Liver Foundation by providing funds to advance life-saving health research and improve the health of Canadians.


Kenroc logo
KENROC
Since 2005, the Kenroc family of companies, including Kenroc Building Materials Co. Ltd., the Sexton Group Co. and Builders Choice Products Co., has named the Canadian Liver Foundation its “prime charity” and has made an incredible investment in liver cancer research in search of new ways to prevent, diagnose, treat or even cure liver cancer.

 

The Canadian Liver Foundation is proud to work with the following organizations with whom we are bringing liver research to life to benefit the liver health of all Canadians. By providing support for CLF national research, education and patient support programs and services, these partners are shaping the future of liver health in Canada.

AbbVie logo

Alexion Logo

Astellas logo

BD Biosciences logo

Gilead Logo

Intercept Logo

Merck logo


For partnership opportunities available please contact Karen Seto.

As a partner of the Canadian Liver Foundation,
not only are you helping bring to life important research, you are becoming part of a network of companies and organizations who are passionate about improving the lives of men, women and children living with liver disease.

Contact us today to get involved in bringing liver research to life.


International Partners

“Working together for liver health around the world”  
The Canadian Liver Foundation strives for innovative ways to partner with liver organizations in Canada and abroad. We are committed to working collaboratively to support liver research and education and to improve the liver health in our respective countries by increasing awareness of the incidence and impact of liver diseases and the importance of liver health. 

Bilateral Partnerships  
The Canadian Liver Foundation has signed a number of international partnership agreements with liver foundations around the world who are committed to sharing and exchanging programs, ideas and strategies and are looking for innovative ways to work collaboratively with the overall goal of improving the lives of people living with or who are at risk for liver disease. 

The CLF welcomes the opportunity to partner with other international liver foundations so that we can help each other work to improve liver health in our home countries. For more information on how to establish a bilateral partnership with the Canadian Liver Foundation, please contact Gary A. Fagan by email or phone at (416) 491-3353

Below is a list of organizations that have established a bilateral partnership with the Canadian Liver Foundation (in alphabetical order by country):

China: Xin Hua Hospital/Shanghai Jaio Tong, University School of Medicine

Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, established in 1958 after the founding of New China in 1949, is a modern comprehensive teaching hospital, integrating functions of providing medical care, serving as an educational base and conducting scientific researches. It has been awarded seven times the title of "Model Unit" of Shanghai, three times the title of "National Advanced Collective" and was granted the title of Class A Hospital at the Tertiary Level (the highest class) in 1993 and honoured as Children-friendly Hospital in 1995.

To learn more, click here.

France: Association Maladies Foie Enfants

AMFE was created in October 2009 by parents of children living with liver disease. This association aims to raise funds for pediatric liver disease research, including biliary atresia. The funds may also be used for social activities to help families cope with the illness of their child.

To learn more, click here.

India: Liver Foundation, West Bengal

Liver Foundation, West Bengal is a voluntary, non-government organization (NGO) registered under the Societies Act 1961. It was founded on June 30, 2006 by a group of health professionals and social activists. Its primary objective is to take the benefits of the advances of medical sciences to the socio-economically backward sections of India. 

To learn more, click here.

Taiwan: Taiwan Liver Research Foundation

The foundation is a non-profitable legal organization whose purpose is to improve the prevention, treatment and research of liver diseases.

To learn more, click here.

United Kingdom: British Liver Trust

The British Liver Trust is the leading liver charity in the UK for all adult liver conditions. The Trust works to pioneer liver health and reduce the impact of liver disease through awareness, care and research. 

To learn more, click here.

United Kingdom: Children's Liver Disease Foundation

Formed in 1980, Children's Liver Disease Foundation (CLDF) is a unique national charity dedicated to fighting all liver diseases of childhood.

Based in Birmingham, CLDF is:

  • a comprehensive information hub for healthcare professionals and the general public
  • a tailored support service for young people with liver disease and their families
  • the lead charity supporting medical research into all aspects of children's liver diseases
  • the voice for young people, their families and adults diagnosed with liver disease in childhood

To learn more, click here.

International Liver Health Alliance  
The International Liver Health Alliance (ILHA) sets a framework for supporting productive international cooperation where the partners will work collaboratively to support public and professional education and liver research and to raise worldwide awareness of the incidence and impact of all forms of liver disease. 

The ILHA welcomes the opportunity to include other interested international liver organizations so that we can work together to improve liver health globally. For more information on how to be a member of the International Liver Health Alliance, please contact Gary A. Fagan by email or phone at (416) 491-3353

Below is a list of members of the International Liver Health Alliance (in alphabetical order by country):

Canada: Canadian Association for the Study of the Liver

CASL is a non-profit organization that seeks to eliminate liver disease through research, education and advocacy. Its members include hepatologists, gastroenterologists, pathologists, pediatricians, radiologists, scientists, surgeons, trainees and other interested people.

To learn more, click here.

Canada: Canadian Liver Foundation

Established in 1969, the Canadian Liver Foundation's mandate is to promote liver health and reduce the incidence and impact of liver disease by providing support for research and education into the causes, diagnoses, prevention and treatment of liver disease.

France: Association Maladies Foie Enfants

AMFE was created in October 2009 by parents of children living with liver disease. This association aims to raise funds for pediatric liver disease research, including biliary atresia. The funds may also be used for social activities to help families cope with the illness of their child.

To learn more, click here.

India: Liver Foundation, West Bengal

Liver Foundation, West Bengal is a voluntary, non-government organization (NGO) registered under the Societies Act 1961. It was founded on June 30, 2006 by a group of health professionals and social activists. Its primary objective is to take the benefits of the advances of medical sciences to the socio-economically backward sections of India. 

To learn more, click here.

Taiwan: Taiwan Liver Research Foundation

The foundation is a non-profitable legal organization whose purpose is to improve the prevention, treatment and research of liver diseases.

To learn more, click here.

United Kingdom: British Liver Trust

The British Liver Trust is the leading liver charity in the UK for all adult liver conditions. The Trust works to pioneer liver health and reduce the impact of liver disease through awareness, care and research. 

To learn more, click here.

United Kingdom: Children's Liver Disease Foundation

Formed in 1980, Children's Liver Disease Foundation (CLDF) is a unique national charity dedicated to fighting all liver diseases of childhood.

Based in Birmingham, CLDF is:

  • a comprehensive information hub for healthcare professionals and the general public
  • a tailored support service for young people with liver disease and their families
  • the lead charity supporting medical research into all aspects of children's liver diseases
  • the voice for young people, their families and adults diagnosed with liver disease in childhood

To learn more, click here.


Research Partnerships

1 in 4 Canadians may be affected by liver disease. While there have been tremendous advances in liver research, significant gaps in knowledge still remain, leaving us with a greater need for collaborative work among organizations that understand the importance of liver research.

The Canadian Liver Foundation is proud to support and work with a robust network of researchers across the country who have made liver research a priority in their labs and clinics. We are truly grateful for the passion and dedication that these researchers demonstrate in their quest to improve the lives of those with liver disease. Together, we can deliver on the CLF’s mission of bringing liver research to life.

Canadian Association for the Study of the Liver (CASL)


CASL logo

The Canadian Association for the Study of the Liver (CASL) serves as the medical association for healthcare professionals and scientists with an interest in liver diseases. This multidisciplinary group consists of Canadian liver specialists (hepatologists), gastroenterologists, basic scientists, hepatobiliary and transplant surgeons, pediatricians, radiologists, pathologists, trainees and other healthcare professionals with an interest in liver disease.

CASL members are charged with the responsibility of being stewards of liver health, not only in taking care of their patients, but also applying their expertise to improve prevention, diagnosis, treatment and care for people with liver disease through research, education and training. Some of the pivotal programs delivered by CASL and supported by the CLF include:

  • Canadian Liver Meeting – a dynamic and comprehensive medical conference to share breakthrough liver research presented in partnership with the Canadian Network on Hepatitis C and the Canadian Association of Hepatology Nurses.
  • CASL Single-Topic Conference – in-depth scientific meetings which focus on several aspects of a particular disease, including perspectives such as clinical, pathogenic factors, therapy and more.
  • Clinical Practice Guidelines – Canadian experts in liver disease providing Canadian healthcare professionals with the information they need to deliver optimum clinical care to their liver patients.
  • Hepatology Fellowship Program – prevention, management and treatment of liver disease is complex and extra training for young physicians is critical for these individuals to become the eventual local, regional, national and international leaders in hepatology.
  • Accreditation – accredited by the Royal College of Physicians and Surgeons of Canada to provide Continuing Professional Development, accredit and co-develop group learning events and self-assessment programs with other physician and non-physician organizations.

Click here to learn more about CASL and to find out how you can become a member.

Canadian National Transplant Research Program (CNTRP)


The Canadian National Transplant Research Program (CNTRP) Logo

The liver is the 2nd most transplanted organ in Canada. With an increase in liver diseases such as fatty liver disease and liver cancer, and with an aging population of people who may have progressive chronic liver disease, the need for liver transplantation is on the rise in Canada.

The Canadian Liver Foundation applauds Canadians and their families who have chosen to offer the gift of life to others through organ donation, however, there are still too few donor organs available to offer to the hundreds of Canadians on the liver transplant waiting list. Sadly, this lack of available donor organs means that many Canadians will die while waiting for a much-needed liver transplant.

With such a critical shortage of organs, it is vital to ensure that every liver transplant has the best possible outcomes and research holds the key. To demonstrate our commitment to improving liver health through research and education, the CLF is proud to be a partner with the Canadian Institutes of Health Research (CIHR) in support of the Canadian National Transplant Research Program (CNTRP). 

The objective of this program is to enhance the survival and quality of life of Canadians who undergo transplantation, through multi-disciplinary, collaborative and leading-edge research. Led by Dr. Lori West of the University of Alberta, the CNTRP connects more than 200 scientists, students, collaborators, patient partners and knowledge-users at 30 sites throughout Canada to carry out research and develop resources to increase access to transplantation and improve survival and quality of life of transplant patients..

The goals for this research on stem cell and solid organ transplant (including liver transplant) are to:
1.    Increase the number of transplants
2.    Extend the life of transplant patients
3.    Improve the quality of life of transplant patients
4.    Develop and enhance training for transplant specialists and researchers
5.    Develop and coordinate a collaborative transplant network
6.    Enhance transplantation data management systems

The CNTRP is supported through the CIHR with $11.25 million plus additional funding from six CIHR partners, including the CLF, of $2.6 million, for a total of $13.85 million. The CNTRP has raised an additional $9.5 million in support from academia, industry, and provincial organ procurement organizations, for a total of $23 million for this transplant research program.

This concentrated focus on improving transplantation through research is an incredible investment in the lives of Canadians who have diseases which have progressed to a point where a transplant may be the only hope for survival. On behalf of all Canadians with or at-risk of liver diseases which may one day progress to the need for a liver transplant, the CLF is honoured to be a partner and a supporter of this research program.

For more information on this program, please visit the CNTRP. 

If you would like to make a donation to support CLF liver transplant research, please click here or contact Karen Seto by email or phone at 1 (800) 563-5483 (Extension 4939).

Canadian Network on Hepatitis C (CanHepC)


The CanHepC Logo

The Canadian Network on Hepatitis C (CanHepC) is a collaborative research network dedicated to research linking over 100 researchers, trainees, knowledge-users (community representatives, policy and decision makers) in the field of hepatitis C from across Canada and internationally.

The goal is to conduct innovative and interdisciplinary research, build research capacity, and translate evidence for uptake into practice and policy, to improve hepatitis C prevention and health outcomes of Canadians and contribute to the global effort to reduce hepatitis C burden worldwide, by focusing on the following themes:

PREVENTION – To improve strategies and interventions to reduce hepatitis C incidence and ultimately prevalence in the Canadian population.

TREATMENT – To enhance strategies to improve treatment access, uptake, adherence, and short and long-term outcomes.

OUTCOMES – To generate evidence-based data on health outcomes of people living with hepatitis C to guide decision making. 

Another major goal of the CanHepC is enhanced training of the next generation of highly qualified personnel. CanHepC recruits and provides support and training to graduate, post-doctoral students and MDs who have demonstrated excellence early in their careers. The training program employs the knowledge and experience of mentors across Canada from multiple disciplines that have played a major role in recent advances in hepatitis C research and their ability to train excellent researchers.

For more information on this program, its mentor and participants, please visit the CanHepC website.

Canadian Network for Autoimmune Liver Disease (CaNAL)

The CaNAL Logo

Established in March 2017 through a partnership between the University of Alberta, University of Calgary and University Health Network (affiliated with University of Toronto), the Canadian Network for Autoimmune Liver Disease (CaNAL) represents a major landmark in Canadian research for autoimmune liver disease. 

To generate significant research impact for the benefit of the patient and develop maximum understanding of the disease, data from many patients is needed.  Because autoimmune liver diseases are uncommon, nationwide collaboration across centres in Canada is essential.

CaNAL will enable several centres and patients to participate in research studies, and will help researchers effectively share and combine data to achieve the following objectives:

1. Develop a Canadian registry of Primary Biliary Cholangitis (PBC) and Autoimmune Hepatitis (AIH) patients.
2. Identify clinical endpoints of end stage liver disease. 
3. Investigate the clinical variants of PBC. 
4. Determine differences in gender/race/ethnicity and clustering of PBC and AIH in aboriginal populations.  
5. Analyze biochemical markers and other factors indicative of early recurrence of PBC and AIH following liver transplantation.

Supported by the partners and by supporters including the Canadian Liver Foundation, CaNAL represents the first national registry of patients with autoimmune liver disease, and provides a powerful platform for much-needed research.